These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9401553)

  • 1. Growth hormone secretagogues in pathological states: diagnostic implications.
    Popovic V; Micic D; Damjanovic S; Obradovic S; Djurovic M; Petakov M; Grudic D; Golubicic I; Nikitovic M; Mitrovic N; Dieguez C; Casanueva FF
    Acta Paediatr Suppl; 1997 Nov; 423():97-101. PubMed ID: 9401553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pituitary GH reserve with GHRP-6.
    Popovic V; Micic D; Damjanovic S; Djurovic M; Simic M; Gligorovic M; Dieguez C; Casanueva FF
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():289-98. PubMed ID: 8887173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related growth hormone-releasing activity of growth hormone secretagogues in humans.
    Arvat E; Camanni F; Ghigo E
    Acta Paediatr Suppl; 1997 Nov; 423():92-6. PubMed ID: 9401552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing peptides.
    Ghigo E; Arvat E; Muccioli G; Camanni F
    Eur J Endocrinol; 1997 May; 136(5):445-60. PubMed ID: 9186261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History to the discovery of ghrelin.
    Bowers CY
    Methods Enzymol; 2012; 514():3-32. PubMed ID: 22975043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone-releasing peptides: clinical and basic aspects.
    Argente J; García-Segura LM; Pozo J; Chowen JA
    Horm Res; 1996; 46(4-5):155-9. PubMed ID: 8950613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone-releasing peptides and their analogs.
    Camanni F; Ghigo E; Arvat E
    Front Neuroendocrinol; 1998 Jan; 19(1):47-72. PubMed ID: 9465289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone in obesity.
    Scacchi M; Pincelli AI; Cavagnini F
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa.
    Giusti M; Foppiani L; Ponzani P; Cuttica CM; Falivene MR; Valenti S
    J Endocrinol Invest; 1997 May; 20(5):257-63. PubMed ID: 9258804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH-related and extra-endocrine actions of GH secretagogues in aging.
    Muller EE; Rigamonti AE; Colonna Vde G; Locatelli V; Berti F; Cella SG
    Neurobiol Aging; 2002; 23(5):907-19. PubMed ID: 12392795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
    Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C
    Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New GH secretagogues and potential usefulness in thalassemia.
    Karydis I; Tolis A; Tolis G
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():857-62. PubMed ID: 10091157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.
    Tannenbaum GS; Bowers CY
    Endocrine; 2001 Feb; 14(1):21-7. PubMed ID: 11322498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ghrelin and growth hormone secretagogues (GHS): modulation of growth hormone secretion and therapeutic applications].
    Correa-Silva SR; Sá LB; Lengyel AM
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):726-33. PubMed ID: 18797578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretagogues in critical illness.
    Van den Berghe G
    Horm Res; 1999; 51 Suppl 3():21-8. PubMed ID: 10592440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone secretagogues in children with altered growth.
    Bercu BB; Walker RF
    Acta Paediatr Suppl; 1997 Nov; 423():102-6. PubMed ID: 9401554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
    Cordido F; Alvarez-Castro P; Isidro ML; Casanueva FF; Dieguez C
    Eur J Endocrinol; 2003 Aug; 149(2):117-22. PubMed ID: 12887288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
    Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus.
    Villas-Boas Weffort RF; Ramos-Dias JC; Chipoch C; Lengyel AM
    Metabolism; 1997 Jun; 46(6):706-10. PubMed ID: 9186309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.